Cancer BiologybioRxivPreprint
A modular patient-derived organoid-xenograft platform reveals molecular and clinical trajectories of prostate cancer progression
Romuald Parmentier, Robin Dolgos, Raphaëlle Servant…·Clémentine Le Magnen
This study establishes a patient-derived organoid-xenograft platform that models prostate cancer progression, identifies biomarkers, and predicts treatment response.